|
CD28 co-stimulation |
|
|
CD28 dependent PI3K/Akt signaling |
|
|
CD28 dependent Vav1 pathway |
|
|
Constitutive PI3K/AKT Signaling in Cancer |
|
|
CTLA4 inhibitory signaling |
|
|
DAP12 signaling |
|
|
Downstream TCR signaling |
|
|
EGFR downregulation |
|
|
EGFR interacts with phospholipase C-gamma |
|
|
EGFR Transactivation by Gastrin |
|
|
GAB1 signalosome |
|
|
Generation of second messenger molecules |
|
|
GPVI-mediated activation cascade |
|
|
GRB2 events in EGFR signaling |
|
|
GRB2 events in ERBB2 signaling |
|
|
Interleukin-2 signaling |
|
|
Nef and signal transduction |
|
|
Nef Mediated CD4 Down-regulation |
|
|
PD-1 signaling |
|
|
PECAM1 interactions |
|
|
Phosphorylation of CD3 and TCR zeta chains |
|
|
PI3K events in ERBB2 signaling |
|
|
PIP3 activates AKT signaling |
|
|
PLCG1 events in ERBB2 signaling |
|
|
Regulation of KIT signaling |
|
|
SHC1 events in EGFR signaling |
|
|
SHC1 events in ERBB2 signaling |
|
|
Signal transduction by L1 |
|
|
Signaling by constitutively active EGFR |
|
|
Signaling by EGFR |
|
|
Signaling by ERBB2 |
|
|
Signaling by ERBB4 |
|
|
Signaling by SCF-KIT |
|
|
Translocation of ZAP-70 to Immunological synapse |
|